407 related articles for article (PubMed ID: 18305140)
1. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
[TBL] [Abstract][Full Text] [Related]
2. CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes.
Mallone R; Martinuzzi E; Blancou P; Novelli G; Afonso G; Dolz M; Bruno G; Chaillous L; Chatenoud L; Bach JM; van Endert P
Diabetes; 2007 Mar; 56(3):613-21. PubMed ID: 17327428
[TBL] [Abstract][Full Text] [Related]
3. Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes.
Ouyang Q; Standifer NE; Qin H; Gottlieb P; Verchere CB; Nepom GT; Tan R; Panagiotopoulos C
Diabetes; 2006 Nov; 55(11):3068-74. PubMed ID: 17065344
[TBL] [Abstract][Full Text] [Related]
4. Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.
Mallone R; Scotto M; Janicki CN; James EA; Fitzgerald-Miller L; Wagner R; Gottlieb P; Thorpe J; Jospe N; Durinovic-Bellò I; Boitard C; Lou O; Dayan CM; Wong FS;
Diabetes Metab Res Rev; 2011 Nov; 27(8):720-6. PubMed ID: 22069251
[TBL] [Abstract][Full Text] [Related]
5. In vivo cytotoxicity of insulin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice.
Jarchum I; Baker JC; Yamada T; Takaki T; Marron MP; Serreze DV; DiLorenzo TP
Diabetes; 2007 Oct; 56(10):2551-60. PubMed ID: 17620420
[TBL] [Abstract][Full Text] [Related]
6. Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men.
Unger WW; Pinkse GG; Mulder-van der Kracht S; van der Slik AR; Kester MG; Ossendorp F; Drijfhout JW; Serreze DV; Roep BO
Ann N Y Acad Sci; 2007 Apr; 1103():192-5. PubMed ID: 17376840
[TBL] [Abstract][Full Text] [Related]
7. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
[TBL] [Abstract][Full Text] [Related]
8. CD8+ T lymphocytes specific for glutamic acid decarboxylase 90-98 epitope mediate diabetes in NOD SCID mouse.
Sévère S; Gauvrit A; Vu AT; Bach JM
Mol Immunol; 2007 Apr; 44(11):2950-60. PubMed ID: 17336387
[TBL] [Abstract][Full Text] [Related]
9. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
10. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.
Unger WW; Velthuis J; Abreu JR; Laban S; Quinten E; Kester MG; Reker-Hadrup S; Bakker AH; Duinkerken G; Mulder A; Franken KL; Hilbrands R; Keymeulen B; Peakman M; Ossendorp F; Drijfhout JW; Schumacher TN; Roep BO
J Autoimmun; 2011 Nov; 37(3):151-9. PubMed ID: 21636247
[TBL] [Abstract][Full Text] [Related]
11. On the pathogenicity of autoantigen-specific T-cell receptors.
Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
[TBL] [Abstract][Full Text] [Related]
12. Modeling competition among autoreactive CD8+ T cells in autoimmune diabetes: implications for antigen-specific therapy.
Marée AF; Santamaria P; Edelstein-Keshet L
Int Immunol; 2006 Jul; 18(7):1067-77. PubMed ID: 16728432
[TBL] [Abstract][Full Text] [Related]
13. Regulatory CD8+ T cells induced by exposure to all-trans retinoic acid and TGF-beta suppress autoimmune diabetes.
Kishi M; Yasuda H; Abe Y; Sasaki H; Shimizu M; Arai T; Okumachi Y; Moriyama H; Hara K; Yokono K; Nagata M
Biochem Biophys Res Commun; 2010 Mar; 394(1):228-32. PubMed ID: 20206130
[TBL] [Abstract][Full Text] [Related]
14. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide.
Han B; Serra P; Amrani A; Yamanouchi J; Marée AF; Edelstein-Keshet L; Santamaria P
Nat Med; 2005 Jun; 11(6):645-52. PubMed ID: 15908957
[TBL] [Abstract][Full Text] [Related]
15. Preproinsulin-specific CD8+ T cells secrete IFNgamma in human type 1 diabetes.
Rathmann S; Rajasalu T; Rosinger S; Schlosser M; Eiermann T; Boehm BO; Durinovic-Belló I
Ann N Y Acad Sci; 2004 Dec; 1037():22-5. PubMed ID: 15699489
[TBL] [Abstract][Full Text] [Related]
16. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
17. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.
Pinkse GG; Tysma OH; Bergen CA; Kester MG; Ossendorp F; van Veelen PA; Keymeulen B; Pipeleers D; Drijfhout JW; Roep BO
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18425-30. PubMed ID: 16339897
[TBL] [Abstract][Full Text] [Related]
18. HLA class I epitope discovery in type 1 diabetes.
van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
[TBL] [Abstract][Full Text] [Related]
19. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice.
Enée E; Martinuzzi E; Blancou P; Bach JM; Mallone R; van Endert P
J Immunol; 2008 Apr; 180(8):5430-8. PubMed ID: 18390725
[TBL] [Abstract][Full Text] [Related]
20. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
Sobel DO; Creswell K
Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
